Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma
| Autor: | Badros, Ashraf, Hyjek, Elizabeth, Ma, Ning, Lesokhin, Alexander, Dogan, Ahmet, Rapoport, Aaron P., Kocoglu, Mehmet, Lederer, Emily, Philip, Sunita, Milliron, Todd, Dell, Cameron, Goloubeva, Olga, Singh, Zeba |
|---|---|
| Zdroj: | In Blood 7 September 2017 130(10):1189-1197 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|